Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05136417 · ClinicalTrials.gov registry record · NA
Study of Intra-Cardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With the Watchman Device
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05136417: Completed NA study, sponsored by Mayo Clinic.
NCT05136417 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05136417, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this research is to to assess the feasibility and safety of left atrial appendage (LAA) occlusion with the WATCHMAN FLX™ device using a standardized intra-procedural intracardiac echocardiography (ICE) protocol under moderate sedation for procedural guidance.
Interventions
- DEVICE intra-procedural intracardiac echocardiography (ICE) probe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2023-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05136417
The ClinicalTrials.gov registry entry for NCT05136417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intra-procedural intracardiac echocardiography (ICE) probe is the first listed.
NCT05136417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05136417 about?
NCT05136417 is a clinical study titled "Study of Intra-Cardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With the Watchman Device". The purpose of this research is to to assess the feasibility and safety of left atrial appendage (LAA) occlusion with the WATCHMAN FLX™ device using a standardized intra-procedural intracardiac echocardiography (ICE) protocol under moderate sedation for procedural guidance.
What is the current status of trial NCT05136417?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2022-01-04. Estimated completion is 2023-12-15.
What interventions are being tested in trial NCT05136417?
The interventions under investigation include: intra-procedural intracardiac echocardiography (ICE) probe (DEVICE).
Who is sponsoring clinical trial NCT05136417?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.